Good Manufacturing Practices (GMP) in Phage Therapy with Dr. Frenk Smrekar, founder and CEO at JAFRAL Podcast Por  arte de portada

Good Manufacturing Practices (GMP) in Phage Therapy with Dr. Frenk Smrekar, founder and CEO at JAFRAL

Good Manufacturing Practices (GMP) in Phage Therapy with Dr. Frenk Smrekar, founder and CEO at JAFRAL

Escúchala gratis

Ver detalles del espectáculo

OFERTA POR TIEMPO LIMITADO | Obtén 3 meses por US$0.99 al mes

$14.95/mes despues- se aplican términos.

Standardizing the phage therapy industry through processes like clinical trails is the way to go . One of the fundamental steps to broader use of phage therapy and successful therapy is producing phages following Good Manufacturing Practices (GMP) and JAFRAL is the leader in this field. In today's show we sit down with JAFRAL's founder and CEO Dr. Frenk Smrekar, a visionary who has been working on the development of GMP for bacteriophages throughout his whole career. Let's give a listen to his journey of founding the company and his observation and thought on the phage therapy field development through a GMP perspective.


Learning more about JAFRAL @https://jafral.com

A review paper on GMP in Phage Therapy by https://doi.org/10.3389/fmicb.2020.01161



Todavía no hay opiniones